Searching for a chemoimmunotherapy signal in patients with non-small-cell lung cancer and EGFR mutations

Lancet Respir Med. 2019 May;7(5):366-367. doi: 10.1016/S2213-2600(19)30112-2. Epub 2019 Mar 25.

Authors

Jose M Pacheco¹, D Ross Camidge²

Affiliations

¹ University of Colorado Cancer Center, Thoracic Oncology Program, 1665 North Aurora Court, Aurora, CO 80045, USA.
² University of Colorado Cancer Center, Thoracic Oncology Program, 1665 North Aurora Court, Aurora, CO 80045, USA. Electronic address: [email protected].

PMID: 30922877
DOI: 10.1016/S2213-2600(19)30112-2

No abstract available

Publication types

Comment

MeSH terms

Antibodies, Monoclonal, Humanized
Bevacizumab
Carcinoma, Non-Small-Cell Lung*
ErbB Receptors / genetics
Humans
Liver Neoplasms*
Lung Neoplasms*
Mutation

Substances

Antibodies, Monoclonal, Humanized
Bevacizumab
atezolizumab
EGFR protein, human
ErbB Receptors